Guizhou Chitianhua Co., Ltd. (600227.SS) operates as a China-based enterprise primarily engaged in chemical manufacturing, pharmaceuticals, medical services, and coal production; its core products include urea fertilizers, synthetic ammonia, ammonium products, methanol, compound fertilizers, anthracite, and thermal coal; pharmaceutical offerings encompass drugs for diabetes, cardiovascular, dermatology, gynecological, digestive, endocrine, and psychotropic conditions, alongside Chinese and Western patent medicines, medical equipment, class II clinical laboratory analysis instruments, sanitary products, and health care items. The company, formerly known as Guizhou Salvage Pharmaceutical Co., Ltd., maintains headquarters in Guizhou Province, China, where it ranks as a major nitrogen fertilizer and methanol producer, with operations centered in domestic markets and supported by coal washing, technology transfer, import-export activities, and motor vehicle maintenance services. In recent developments, its wholly-owned subsidiary Tongzi Chemical completed a planned 35-day maintenance shutdown on September 25, 2025, and resumed normal production operations, reflecting ongoing efforts to optimize chemical facility performance amid its dual focus on coal chemicals and big health industries.